Glenmark Life Sciences Limited

Glenmark Life Sciences Limited IPO

BSE, NSEClosed
Jul 27, 2021Open Date
Jul 29, 2021Close Date
TBAAllotment Date
Aug 6, 2021Listing Date

Subscription Details

View Subscription Details
QIB37.30x
Retail15.00x
NIIs (Non-Institutional Investors)Main Category
125.62x

Overall Subscription

Total Bids Received

45.08x

Updated: 10 Jul, 06:09 pm

Glenmark Life Sciences Limited IPO Issue Details

Issue Price₹695-720 Per Equity Share
Face Value₹2 Per Equity Share
Listing AtBSE, NSE
Listing DateAug 6, 2021

Company Information

Glenmark Life Sciences is the leading manufacturer of Active Pharmaceutical Ingredients (APIs). The company develops, manufactures, and supplies high-quality APIs for cardiovascular disease (CVS), cen...

Valuations

RoNW

46.71%

Financial Information (₹ in Crores)

MetricFY 21FY 20FY 19
Total Assets1997.071725.61475.39
Total Revenue1885.971549.3886.86
Profit After Tax351.58313.09195.59
Net Worth

* All figures are in ₹ Crores unless otherwise stated.

Objectives of the Issue

  1. 1To make payment of outstanding purchase consideration to the promoter for the spin-off of the API business from the promoter into the company.
  2. 2To finance capital expenditure requirements.
  3. 3To meet general corporate purposes.

Glenmark Life Sciences Limited – Promoter(s)

Glenmark Pharmaceuticals Limited

Contact Details

Visit Website

Glenmark Life Sciences Limited IPO Documents

DRHP
RHP

Frequently Asked Questions — Glenmark Life Sciences Limited IPO

Download Mobile App

Get push notifications instantly when IPO allotment goes live!

GET IT ONGoogle Play
DOWNLOADApp Store

Angel One

Free Demat

Zero Brokerage Equity

Angel One
Open Account Now

Zerodha

Free Demat

India's #1 Stock Broker

Zerodha
Open Account Now

Upstox

Free Demat

Instant Demat Account

Upstox
Open Account Now